Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells

Hypertension Research

Volumn 24, Issue 3, 2001, Pages 251-261

  Kyaw, M ^a   Yoshizumi, M ^a   Tsuchiya, K ^a   Kirima, K ^a   Tamaki, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiotensin II; Antioxidant; Mitogen activated protein kinase; Oxygen consumption; Vascular smooth muscle cell

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; DIETHYLDITHIOCARBAMIC ACID; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TROLOX C;

ANIMAL CELL; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HYPOTHESIS; MALE; NONHUMAN; OXYGEN CONSUMPTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ACETYLCYSTEINE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ASCORBIC ACID; CELLS, CULTURED; CHELATING AGENTS; CHROMANS; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; ONIUM COMPOUNDS; OXYGEN CONSUMPTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VASOCONSTRICTOR AGENTS;

EID: 0034975973     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.251     Document Type: Article

References (45)

1. Angiotensin II receptor antagonists: An emerging new class of cardiovascular therapeutics
2. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
3. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system
4. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
5. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits
6. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
7. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
8. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
9. phox in human coronary arteries
10. Rapid and preferential activation of the c-jun gene during the mammalian UV response
11. Involvement of reactive oxygen species in cytokine and growth induction of c-fos expression in chondrocytes
12. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
13. Modulation of fibroblast proliferation by oxygen free radicals
14. Free radicals as mediators of tissue injury and disease
15. Free radicals, reactive oxygen species and human disease: A critical evaluation with special reference to atherosclerosis
16. Reactive oxygen species as mediators of signal transduction in cardiovascular disease
17. Theodore Cooper Memorial Lecture: Hypertension and the pathogenesis of atherosclerosis: Oxidative stress and the mediation of arterial inflammatory response: A new perspective
18. The role of oxidized lipoproteins in atherogenesis
19. 2 for platelet-derived growth factor signal transduction
20. Activation of extracellular-regulated kinases (ERK 1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
21. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: Role in vascular smooth muscle cell hypertrophy
22. Vitamin E consumption and the risk of coronary heart disease in men
23. Randomised controlled trial of vitamin E in patients with coronary disease
24. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
25. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production
26. ·- production in the pig coronary artery
27. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: A possible role for antioxidants in restenosis
28. Beneficial effects of vitamin E treatment in acute myocardial infarction
29. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
30. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species
31. Oxidation of hydroquinone by copper: Chemical mechanism and biological effects
32. Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle
33. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle
34. phox and reactive oxygen species
35. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells
36. ·- in vascular smooth muscle cells
37. The biology of oxygen radicals
38. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells
39. The antioxidants of human extracellular fluids
40. Biology of free radical scavengers: An evaluation of ascorbate
41. Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited
42. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production
43. In vitro lipid peroxidation of human serum catalyzed by cupric ion: Antioxidant rather than prooxidant role of ascorbate
44. Action of ascorbic acid as a scavenger of active and stable oxygen radicals
45. Combination of vitamins C and E alters the response to coronary balloon injury in the pig